Smith & Nephew Plc Director/PDMR Shareholding (7324Y)
May 14 2021 - 10:00AM
UK Regulatory
TIDMSN.
RNS Number : 7324Y
Smith & Nephew Plc
14 May 2021
SMITH & NEPHEW PLC
14 May 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
Reason for the notification
Initial notification /Amendment Initial notification
-------------------------------------------------
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
Name Smith & Nephew plc
-------------------------------------------------
LEI 213800ZTMDN8S67S1H61
-------------------------------------------------
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
Description of the financial Smith & Nephew plc ordinary shares of USD
instrument, type of instrument 0.20 each
-------------------------------------------------
Identification code ISIN: GB0009223206
-------------------------------------------------
Nature of the transaction Purchase of ordinary shares through the
Company's Dividend Re-Investment Plan following
the 2020 final dividend payment on 12 May
2021.
-------------------------------------------------
Date of Transaction 2021 - 05 - 12
-------------------------------------------------
Place of Transaction London Stock Exchange (XLON)
-------------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Director Aggregated the transaction the transaction
Name (Position) / PDMR Price Volume information * *
Bradley Cannon 77,295.40344
(President (including
Sports Medicine N/A Single 2,101.64550
& ENT) PDMR GBP15.269779 129.64031 Transaction in ADS') 0.00873%
---------- -------------- ---------- ------------- ----------------- -----------------
Phil Cowdy
(Chief Business
Development
& Corporate N/A Single
Affairs Officer) PDMR GBP15.269779 112.08811 Transaction 45,410.28786 0.00513%
---------- -------------- ---------- ------------- ----------------- -----------------
Myra Eskes
(President N/A Single
APAC Region) PDMR GBP15.269779 197.38513 Transaction 18,332.32816 0.00207%
---------- -------------- ---------- ------------- ----------------- -----------------
Simon Fraser
(President
Advanced Wound N/A Single
Management) PDMR GBP15.269779 92.76422 Transaction 8,615.56333 0.00097%
---------- -------------- ---------- ------------- ----------------- -----------------
Mark Gladwell
(President
Operations N/A Single
& GBS) PDMR GBP15.269779 96.46099 Transaction 96.90438 0.00001%
---------- -------------- ---------- ------------- ----------------- -----------------
Melissa Guerdan
(Chief Quality
& Regulatory N/A Single
Affairs Officer) PDMR GBP15.269779 99.85666 Transaction 9,274.28002 0.00105%
---------- -------------- ---------- ------------- ----------------- -----------------
Skip Kiil
(President N/A Single
Orthopaedics) PDMR GBP15.269779 99.50036 Transaction 12,128.03780 0.00137%
---------- -------------- ---------- ------------- ----------------- -----------------
Catheryn O'Rourke 82,100.55347
(Chief Legal (including
& Compliance N/A Single 5,818.25734
Officer) PDMR GBP15.269779 583.31782 Transaction in ADS') 0.00928%
---------- -------------- ---------- ------------- ----------------- -----------------
Susan Swabey N/A Single
(Company Secretary) PDMR GBP15.269779 190.40720 Transaction 49,416.24672 0.00558%
---------- -------------- ---------- ------------- ----------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFESESISLIL
(END) Dow Jones Newswires
May 14, 2021 11:00 ET (15:00 GMT)
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Apr 2024 to May 2024
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From May 2023 to May 2024